Nasenspray Neo Spirig HC 0.05 % Spray nasale

Country: Svizzera

Lingwa: Taljan

Sors: Swissmedic (Swiss Agency for Therapeutic Products)

Ingredjent attiv:

xylometazolini hydrochloridum

Disponibbli minn:

Spirig HealthCare AG

Kodiċi ATC:

R01AA07

INN (Isem Internazzjonali):

xylometazolini hydrochloridum

Għamla farmaċewtika:

Spray nasale

Kompożizzjoni:

xylometazolini hydrochloridum 0.5 mg/ml corresp. xylometazolini hydrochloridum 45 µg pro dosi, kalii dihydrogenophosphas, aqua maris, aqua purificata ad solutionem pro 1 ml, doses pro vase 100.

Klassi:

D

Grupp terapewtiku:

Synthetika

Żona terapewtika:

Nasenschleimhautentzündung

L-istatus ta 'awtorizzazzjoni:

zugelassen

Data ta 'l-awtorizzazzjoni:

2023-03-20